Key result
Experimental inoculation of Rhesus monkeys with TTV resulted in persistent viremia and fecal excretion for over 6 months without significant liver pathology or elevated transaminases.
Answers are grounded in this paper and cite their sources.
TTV can establish a persistent, nonpathogenic infection in Rhesus monkeys via both oral and parenteral routes.
Virus fragments homologous to TTV were detected previously from an enterically transmitted outbreak of non-A-E hepatitis [Luo et al., 1999]. To test the susceptibility of the Rhesus monkey to this virus and to establish its transmission routes, 6 Rhesus monkeys were inoculated, 3 orally and another 3 intravenously. The inoculum was prepared by extracting and filtering feces collected from a patient during the incubation period identified in the described outbreak. A second group of 3 monkeys was used for the passage study. The feces and blood samples were collected for detection of the virus by polymerase chain reaction (PCR). Four animals were subjected to liver biopsies and bile aspiration by open surgery for in situ virus detection. Viremia occurred in 4-7 days after intravenous and 7-10 days after oral inoculation. The virus was excreted in feces a few days after oral infection and simultaneously with viremia after intravenous inoculation. The virus was also detected in bile during the viremic phase. There was a prolonged carrier state with persistent viremia and virus excretion in feces for more than 6 months. Serum transaminase levels were not raised during the infection. The virus was present in both the cytoplasm and nuclei of hepatocytes, but no significant pathology was found. Therefore, the Rhesus monkey is susceptible to TT virus infection, but the virus seems nonpathogenic. Infection of the liver may be established either by oral or parenteral inoculation. The virus may be released from liver into the blood or via bile into feces, so it may be transmitted by both blood and fecal routes.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2000) studied TTV infection (n=9). TTV inoculation (oral or intravenous) was evaluated on Viremia, virus excretion, and liver pathology. Experimental inoculation of Rhesus monkeys with TTV resulted in persistent viremia and fecal excretion for over 6 months without significant liver pathology or elevated transaminases.
Synapse has enriched 10 related papers. Consider them for comparative context: